Structured page family:App landing

GLP-1 Weekly Reminder

GLP-1 receptor agonists require consistent weekly dosing to maintain steady-state plasma concentrations. Missing injections — or spacing them unevenly — disrupts the plasma level plateau that underpins the drug's effectiveness. The GLP-1 Reminder is a lightweight, privacy-first scheduler that stores your injection day, sends browser-based alerts before each weekly dose, and tracks your escalation schedule so you always know what dose comes next.

Launch State
The GLP-1 Reminder is in development as part of the PeptideScholar tracker suite. Join the waitlist to receive early access when the web-based version launches.
Planned Features
  • Weekly injection day reminder with configurable alert timing
  • Dose escalation schedule tracking (e.g. 0.25 mg → 0.5 mg → 1 mg → 2.4 mg)
  • Next injection countdown with days-remaining display
  • Missed dose flag with official guidance link
  • Refill timing alert based on pen or vial supply count
Privacy and Scope

Reminder schedules are stored locally in your browser. No account is required and no injection data is sent to PeptideScholar servers. The reminder uses browser notification permissions only — no background data collection.

Compare cost and provider paths →
Trust Summary
Reviewed 2026-04-13 by PeptideScholar editorial review. This page currently cites 3 official sources.
This landing page describes a planned reminder workflow. Reminder tools are adherence aids, not medical devices. Missed dose decisions, dose escalation timing, and injection technique should still follow official prescribing information and clinician guidance.
Or skip the waitlist
The local-first tracker beta is already live for dose logs, symptoms, and reminders.
Open tracker →

Join the GLP-1 Reminder waitlist

The GLP-1 Reminder is in development as part of the PeptideScholar tracker suite. Join the waitlist to receive early access when the web-based version launches.

No spam. Unsubscribe anytime.

GLP-1 Weekly Reminder FAQ

Sources

  1. 1. Adherence to GLP-1 Receptor Agonist Therapy: A Systematic Review
    Diabetes Therapy • 2022
    Claim type: clinical
    View source →
  2. 2. Wegovy (semaglutide) Prescribing Information — Missed Dose Instructions
    FDA / Novo Nordisk • 2023
    Claim type: clinical
    View source →
  3. 3. Mounjaro (tirzepatide) Prescribing Information — Missed Dose Instructions
    FDA / Eli Lilly • 2023
    Claim type: clinical
    View source →

This content is for informational purposes only and does not constitute medical advice.